Physician profile
Norris Tran Duc
NPI 1659791572
$25,043.42
in general payments reported to CMS, 2019-2025
11 companies · $19K in 2025
The $19K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $131 · 2021: $1,253 · 2022: $1,399 · 2023: $1,350 · 2024: $2,169 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $6,123 · Travel and Lodging: $1,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,950.00 |
| Food and Beverage | $6,122.66 |
| Travel and Lodging | $1,062.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $19,900.83 | 2019-2025 | Apretude, Dovato, Cabenuva |
| Gilead Sciences, INC. | $2,243.98 | 2020-2025 | Biktarvy, Yeztugo |
| Theratechnologies INC. | $1,389.64 | 2021-2025 | Trogarzo, Egrifta |
| Merck Sharp & Dohme LLC | $422.68 | 2020-2025 | Delstrigo, Pifeltro |
| Emd Serono, INC. | $369.74 | 2024-2025 | Serostim |
| Janssen Products, LP | $295.18 | 2021-2022 | |
| Pfizer INC. | $194.58 | 2024-2025 | |
| Glaxosmithkline, LLC. | $119.05 | 2025 | Blujepa |
| Napo Pharmaceuticals INC | $50.52 | 2025 | Mytesi |
| Amgen INC. | $38.87 | 2025 | Repatha |
| Exact Sciences Corporation | $18.35 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norris Tran Duc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.